CLINICAL_TRIALS
trial_result
· 2020-04-30
Clinical Trial Update: Phase II Pharmacokinetics Study of CAM2038 [Phase 2]
Summary
Phase II pharmacokinetics study of CAM2038 completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Braeburn Pharmaceuticals | Conditions: Opioid Use Disorder, Chronic Pain | Phase 2 | Status: COMPLETED | Results posted: 2020-04-30